NCT00001512
- Conditions
- B Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Clinical trial condition
B Cell Lymphoma
Explore clinical trials studying B Cell Lymphoma. Study availability and eligibility vary by location and protocol.
40 public trials
13 recruiting studies
B Cell Lymphoma trial results
NCT00001572
- Conditions
- B Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT01148108
- Conditions
- B Cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +19 more
- Locations
-
- Cancer Institute of New Jersey New Brunswick, New Jersey, United States
NCT00741871
- Conditions
- B Cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +12 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT00001271
- Conditions
- B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- National Cancer Institute (NCI) Bethesda, Maryland, United States
Active, Not Recruiting
Phase II Palbociclib +Ibrutinib in Mantle Cell Lymphoma
NCT03478514
- Conditions
- B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- University of Maryland, Greenebaum Comprehensive Cancer Center Baltimore, Maryland, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- St. Joseph Mercy Hospital Cancer Care Center Ypsilanti, Michigan, United States
Active, Not Recruiting
Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma
NCT05412290
- Conditions
- Aggressive Lymphoma, B Cell Lymphoma, Diffuse Large B Cell Lymphoma, +15 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
Active, Not Recruiting
CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLL
NCT00586391
- Conditions
- Acute Lymphocytic Leukemia, B Cell Lymphoma, Chronic Disease, +20 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
- Texas Children's Hospital Houston, Texas, United States
Active, Not Recruiting
Occurrence of Acute Kidney Injury After CAR-T Cells Treatments in B-cell Lymphoma.
NCT07101913
- Conditions
- Acute Kidney Injury, Acute Kidney Injury (AKI), B Cell Lymphoma, +18 more
- Locations
-
- Nephrology department, Centre hospitalier Lyon Sud Pierre-Bénite, France
Active, Not Recruiting
Pembrolizumab in Combination With Chemotherapy for Patients With Untreated B Cell Lymphoma
NCT03995147
- Conditions
- B Cell Lymphoma, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- The University of Chicago Chicago, Illinois, United States